Company: LNAI
Filing Date: 2025-12-03
Form Type: 424B5
Source: 0001731122-25-001626
Chunk: 27

Company: Lunai Bioworks Inc.
Filing Date: 2025-12-03
Form: 424B5
Chunk 27
---
. Such investments
and securities activities may
involve securities and/or instruments of ours
or our affiliates. Dawson James or its affiliates
may also make investment
recommendations and/or publish or express independent
research views in respect of such securities or financial
instruments and may hold, or recommend to clients
that they acquire, long and/or short positions in such securities
and instruments.

<div align='center'>S-18

LEGAL M ATTERS</div>

The validity
of the Common Stock offered hereby will be passed
upon for us by Dickinson Wright PLLC, Fort Lauderdale, FL. Dawson James is being represented
in connection with this offering by Nelson Mullins
Riley & Scarborough LLP, Raleigh, NC.

<div align='center'>EXPE RTS</div>

The audited financial statements
incorporated by reference in this prospectus and elsewhere in the registration statement
have been so incorporated by reference in reliance upon the report of Sadler, Gibb & Associates, LLC, independent registered
public accountants, upon the authority of said firm as experts in accounting
and auditing.

<div align='center'>WHERE YOU CAN FIND MORE INFORM ATION</div>

We have
filed a registration statement on Form S-3 with the SEC under the Securities Act of 1933 with
respect to the shares of Common Stock offered
by this prospectus supplement. This prospectus supplement
and the accompanying prospectus
are part of the registration statement but the
registration statement includes and incorporates
by reference additional information and exhibits.
This prospectus supplement does not contain all
the information set forth in the registration
statement and its exhibits and schedules, portions
of which have been omitted as
permitted by the rules and regulations of the SEC. For further information
about us, we refer you to the registration statement
and to its exhibits and schedules. Certain information
in the registration statement has
been omitted from this prospectus
supplement and the accompanying prospectus in
accordance with the rules of the SEC. We file
annual, quarterly and current reports, proxy statements
and other information with the SEC.
The SEC maintains a website that contains reports,
proxy and information statements and other information regarding companies, such
as ours, that file documents electronically with the SEC.
The address of that website is http://www.sec.gov.
The information on the SEC’s website is not part of this prospectus
supplement or the accompanying prospectus, and
any references to this website or any